{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:01:55Z","timestamp":1775660515969,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Society of Allergology","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":848,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2332\/allergolint.12-oa-0510","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T23:00:31Z","timestamp":1370905231000},"page":"245-249","source":"Crossref","is-referenced-by-count":14,"title":["Comparing the Effects of Botulinum Toxin-A and Cetirizine on the Treatment of Allergic Rhinitis"],"prefix":"10.2332","volume":"62","author":[{"given":"Sayyed Mostafa","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Okhovat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saghi","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Pourghasemian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.12-OA-0510_bb0005","first-page":"181","article-title":"Frequency of allergic rhinitis in school-age children (7-18 Years) in Tehran","volume":"2","author":"Mirsaid Ghazi","year":"2003","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2222.2011.03891.x","article-title":"Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America","volume":"42","author":"Katelaris","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.2332\/allergolint.12-OA-0510_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1513\/pats.201008-057RN","article-title":"Pathophysiology of allergic and nonaller- gic rhinitis","volume":"8","author":"Sin","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.2332\/allergolint.12-OA-0510_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1398-9995.1997.tb04817.x","article-title":"Autonomic reflexes and non-allergic rhinitis","volume":"52","author":"Jones","year":"1997","journal-title":"Allergy"},{"issue":"Suppl 86","key":"10.2332\/allergolint.12-OA-0510_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-OA-0510_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1513\/pats.201004-033RN","article-title":"Overview of the treatment of allergic rhinitis and nonallergic rhinopathy","volume":"8","author":"Greiner","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.2332\/allergolint.12-OA-0510_bb0035","first-page":"80","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","author":"Schantz","year":"1992","journal-title":"Micro- biolRev"},{"key":"10.2332\/allergolint.12-OA-0510_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0045","first-page":"RA40","article-title":"Emerging therapeutic applications of botulinum toxin","volume":"9","author":"Thant","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.2332\/allergolint.12-OA-0510_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1746-160X-5-18","article-title":"Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis","volume":"5","author":"Rohrbach","year":"2009","journal-title":"Head Face Med"},{"key":"10.2332\/allergolint.12-OA-0510_bb0055","doi-asserted-by":"crossref","first-page":"36771","DOI":"10.1016\/j.otohns.2008.06.031","article-title":"A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy","volume":"139","author":"Yang","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.2332\/allergolint.12-OA-0510_bb0060","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/00016489.2003.11720744","article-title":"Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial","volume":"123","author":"Unal","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1034\/j.1398-9995.2003.00079.x","article-title":"Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma","volume":"58","author":"Baiardini","year":"2003","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-OA-0510_bb0070","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.anai.2010.10.014","article-title":"The economic impact of allergic rhinitis and current guidelines for treatment","volume":"106","author":"Meltzer","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-7961-9-5","article-title":"Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway","volume":"9","author":"Thorn","year":"2011","journal-title":"Clin Mol Allergy"},{"key":"10.2332\/allergolint.12-OA-0510_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S0022215100158281","article-title":"The effect of botu- linum toxin type A injection for intrinsic rhinitis","volume":"112","author":"Kim","year":"1998","journal-title":"J Laryn- gol Otol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/000348940111001110","article-title":"Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs","volume":"110","author":"Rohrbach","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjoto.2006.01.008","article-title":"The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis","volume":"27","author":"\u00d6zcan","year":"2006","journal-title":"Am J Otolaryngol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjoto.2011.01.004","article-title":"Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study","volume":"33","author":"Braun","year":"2012","journal-title":"Am J Otolaryngol"},{"key":"10.2332\/allergolint.12-OA-0510_bb0100","first-page":"45","article-title":"Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia","volume":"46","author":"Sapci","year":"2008","journal-title":"Rhinology"},{"key":"10.2332\/allergolint.12-OA-0510_bb0105","first-page":"223","article-title":"Investigate the effect of botulinum toxin type A (BTX-A) on nasal symptoms inpatients with allergic rhinitis","volume":"125","author":"Unal","year":"2005","journal-title":"Acta Otolaryngol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015301337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015301337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T03:01:01Z","timestamp":1563159661000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015301337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1323893015301337"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.12-oa-0510","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}